Two-Thirds of U.S. Adults Self-Monitor Heart Health
By Lori Solomon HealthDay Reporter
MONDAY, Feb. 3, 2025 -- The majority of U.S. adults use a device on a regular basis to monitor their heart health, but only one in four uses those data to have a conversation about their heart health with their doctor, according to the results of a survey released Jan. 22 by The Ohio State University Wexner Medical Center in Columbus.
The survey included web and telephone responses from 1,008 U.S. adults gathered in December 2024.
The results showed that nearly two-thirds of respondents use a device on a regular basis to monitor their heart health, including smartwatches (32 percent), portable blood pressure machines (31 percent), fitness apps (19 percent), or wearable fitness/movement trackers (13 percent). Of those who self-monitor, only one in four reported using those data in conversations with their doctor.
"These self-monitoring devices are really helpful to patients and their health care providers because they can potentially catch things early," Laxmi Mehta, M.D., from The Ohio State University, said in a statement. "If patients are monitoring their blood pressure at home and notice it's been going up over time, they may want to discuss it with their doctor sooner rather than waiting for their annual visit. Or they may capture some irregular heart rhythms on their devices, like atrial fibrillation, much sooner than would be diagnosed at the doctor's office."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-02-05 00:00
Read more
- Multiparametric MRI Expedites Treatment in Muscle-Invasive Bladder Cancer
- Capricor Therapeutics Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
- Lifetime Cancer Risk Might Be Set Before You're Born
- Perioperative Chemo With FLOT Ups Survival in Resectable Esophageal Cancer
- Guidelines Developed to Address Infections Tied to Regional Anesthesia
- Key CDC Health Websites Vanish Following Trump Orders
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions